- CA$200.23m
- CA$230.15m
- CA$194.32m
- 53
- 69
- 77
- 73
R2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 173 | 145 | 126 | 159 | 194 |
Cost of Revenue | |||||
Gross Profit | 76.9 | 58.9 | 37.4 | 37.8 | 40.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 154 | 137 | 153 | 209 | 218 |
Operating Profit | 18.8 | 7.38 | -27.8 | -49.8 | -24.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 20.3 | 9.27 | -26.7 | -47.3 | -33.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11.1 | 4.43 | -22.2 | -54.2 | -43.8 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 12.7 | 18.7 | -22.2 | 2.77 | -65.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 12.7 | 18.7 | -22.2 | 2.77 | -65.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.105 | 0.044 | -0.16 | -0.358 | -0.327 |
Dividends per Share |